Richard Pzena - Pzena Investment Management
Superinvestor profile · Rank #12 of 149 tracked managers by reported 13F value · CIK 0001027796 · All profiles
Founded 1995New York City, New York, U.S.Deep value, long-onlyKey person: Richard S. Pzena (founder, chairman, CEO and co-CIO)
Reported 13F value
$34.1B
Period 2026-06-30 · Filed 2026-08-07
Positions
161
Top 10 = 37.6% of value
Clone CAGR (full window)
+11.1%
2016-11-04 → 2026-10-02 · cumulative +185%
SPY CAGR (same window)
+15.9%
Cumulative +332%
Max drawdown (monthly)
-39%
Month-end values, approximate
Latest-quarter activity
12 new · 9 exited
71 increased · 70 decreased
Hypothetical clone — not this fund's returns. The performance on this page replicates only the long U.S. equity positions disclosed on this manager's Form 13F filings, rebalanced on filing dates at disclosed weights with dividend-adjusted prices. It excludes shorts, bonds, cash, non-U.S. listings, private holdings, leverage and fees. Treat it as a measure of how the disclosed stock picks performed, never as the fund's track record. Evidence: filing-by-filing dossier (PDF) · Methodology (PDF)
Clone performance
| Window | Clone CAGR | Note |
|---|---|---|
| Full window (2016-11-04 → 2026-10-02, 40 filings) | +11.13% | Cumulative +184.6% vs SPY +332.1% |
| Trailing 10Y | — | |
| Trailing 5Y | +9.63% | |
| Trailing 3Y | +13.55% | |
| Trailing 1Y | +16.48% |
Top holdings — 2026 Q2 filing
| Ticker | Company | Weight | Reported value |
|---|---|---|---|
| MGA | Magna Intl Inc | 6.54% | $2.2B |
| HUM | Humana Inc | 5.13% | $1.7B |
| BAX | Baxter Intl Inc | 4.09% | $1.4B |
| CVS | Cvs Health Corp | 3.57% | $1.2B |
| DG | Dollar Gen Corp | 3.45% | $1.2B |
| SWKS | Skyworks Solutions Inc | 3.18% | $1.1B |
| CTSH | Cognizant Technology Solutio | 3.02% | $1.0B |
| BMY | Bristol-Myers Squibb Co | 2.88% | $980M |
| TSN | Tyson Foods Inc | 2.86% | $974M |
| CRBG | Corebridge Finl Inc | 2.84% | $967M |
As reported on the 2026-06-30 Form 13F (filed 2026-08-07). Full holdings and quarter changes: holdings page.
Filing history in this profile
Every clone input traces to one of these SEC filings. 89.9% of the latest filing's reported value is covered by our price history; the remainder is mostly non-U.S. listings, recent IPOs or delisted names and is excluded from the clone.
| Quarter | SEC accession no. | Filed | Disclosed CUSIPs |
|---|---|---|---|
| 2026Q2 | 0001027796-26-000049 | 2026-08-07 | 161 |
| 2026Q1 | 0001027796-26-000024 | 2026-04-24 | 158 |
| 2025Q4 | 0001027796-26-000009 | 2026-02-06 | 157 |
| 2025Q3 | 0001027796-25-000057 | 2025-11-07 | 154 |
| 2025Q2 | 0001027796-25-000043 | 2025-07-25 | 152 |
| 2025Q1 | 0001027796-25-000029 | 2025-05-02 | 146 |
| 2024Q4 | 0001027796-25-000014 | 2025-02-07 | 152 |
| 2024Q3 | 0001027796-24-000048 | 2024-11-08 | 157 |
| 2024Q2 | 0001027796-24-000014 | 2024-08-02 | 160 |
| 2024Q1 | 0001027796-24-000007 | 2024-05-03 | 159 |
| 2023Q4 | 0001027796-24-000004 | 2024-02-09 | 164 |
| 2023Q3 | 0001140361-23-052439 | 2023-11-09 | 160 |
| 2023Q2 | 0001140361-23-038068 | 2023-08-04 | 161 |
| 2023Q1 | 0001140361-23-024367 | 2023-05-12 | 163 |
| 2022Q4 | 0001140361-23-004425 | 2023-02-03 | 180 |
| 2022Q3 | 0001140361-22-041191 | 2022-11-14 | 175 |
| 2022Q2 | 0001567619-22-015049 | 2022-08-05 | 168 |
| 2022Q1 | 0001567619-22-009665 | 2022-05-06 | 177 |
| 2021Q4 | 0001567619-22-002512 | 2022-02-04 | 174 |
| 2021Q3 | 0001567619-21-019397 | 2021-11-05 | 168 |
| 2021Q2 | 0001567619-21-014637 | 2021-08-06 | 165 |
| 2021Q1 | 0001567619-21-009298 | 2021-05-07 | 170 |
| 2020Q4 | 0001567619-21-002265 | 2021-02-05 | 166 |
| 2020Q3 | 0001567619-20-018403 | 2020-10-30 | 167 |
| 2020Q2 | 0001567619-20-013978 | 2020-07-31 | 169 |
| 2020Q1 | 0001567619-20-008779 | 2020-05-01 | 165 |
| 2019Q4 | 0001567619-20-002400 | 2020-02-07 | 174 |
| 2019Q3 | 0001567619-19-020281 | 2019-11-01 | 175 |
| 2019Q2 | 0001567619-19-015705 | 2019-08-02 | 172 |
| 2019Q1 | 0001567619-19-009752 | 2019-05-03 | 171 |
| 2018Q4 | 0001567619-19-002790 | 2019-02-08 | 183 |
| 2018Q3 | 0001567619-18-005554 | 2018-11-09 | 183 |
| 2018Q2 | 0001140361-18-035372 | 2018-08-03 | 161 |
| 2018Q1 | 0001140361-18-021745 | 2018-05-04 | 157 |
| 2017Q4 | 0001140361-18-006290 | 2018-02-09 | 156 |
| 2017Q3 | 0001140361-17-040951 | 2017-11-03 | 151 |
| 2017Q2 | 0001140361-17-030245 | 2017-08-04 | 152 |
| 2017Q1 | 0001140361-17-018609 | 2017-05-05 | 155 |
| 2016Q4 | 0001140361-17-005785 | 2017-02-10 | 157 |
| 2016Q3 | 0001140361-16-084894 | 2016-11-04 | 152 |
Background (founded / HQ / style) source: https://smartasset.com/financial-advisor/pzena-investment-management-review — Founded in 1995 by Richard Pzena (formerly of Sanford C. Bernstein); began officially managing assets on January 1, 1996. Formerly NYSE-listed, the firm was taken private in October 2022. HQ at 320 Park Avenue, New York.